Colorectal

Videos

Refining Adjuvant Treatment Options for Colorectal Cancer

09/18/2019

Elena Elez, MD, PhD, explains how to refine the selection of adjuvant treatment for stage II colorectal cancer.

Elena Elez, MD, PhD, explains...

09/18/2019

Oncology

Methods and Sequencing for First- and Next-Line Therapy of CRC

09/14/2019

At the 2019 Great Debates & Updates in GI Malignancies meeting, Jeffrey A. Meyerhardt, MD, MPH, provided an update on the latest approaches for the first- and next-line treatment of CRC.

At the 2019 Great Debates &...

09/14/2019

Oncology

Videos

Targeted Therapy as Early Treatment for BRAF V600E-Mutated CRC

09/13/2019

Scott Kopetz, MD, PhD, FACP, discusses using targeted therapy earlier in the treatment of patients with CRC and BRAF V600E mutation.

Scott Kopetz, MD, PhD, FACP,...

09/13/2019

Oncology

The Biologically Distinct Threat of Early-Onset CRC

09/13/2019

At the 2019 Great Debates & Updates in GI Malignancies meeting, Mark A. Lewis, MD, provided an update on the biologically distinct threat of early-onset CRC.

At the 2019 Great Debates &...

09/13/2019

Oncology

Videos

What is New in Anal Cancer in the Last 12 Months?

09/12/2019

Cathy Eng, MD, FACP, FASCO, discusses the latest developments in anal cancer over the past 12 months.

Cathy Eng, MD, FACP, FASCO,...

09/12/2019

Oncology

Debates and Roundtables

Expert Roundtable: BEACON Trial Yields Novel Therapy for BRAFV600E–Mutated CRC

08/13/2019

Axel Grothey, MD; Josep Tabernero, MD, PhD; and Scott Kopetz, MD, PhD, FACP, discuss the findings and clinical significance of the BEACON CRC trial.

Axel Grothey, MD; Josep...

08/13/2019

Oncology

Flexible Regorafenib Dosing Shows Promise as Alternative Therapy for Metastatic CRC

07/06/2019

Flexible regorafenib dosing is promising as an alternative therapy option for patients with metastatic CRC, according to results from the REARRANGE trial presented for the first time at the ESMO 21st World Congress on Gastrointestinal Cancer

Flexible regorafenib dosing is...

07/06/2019

Oncology

Triplet Combo Regimen Defines New Standard of Care for Patients With BRAF V600E-Mutant Metastatic CRC

07/06/2019

New data from a recent study show improved survival and responses in patients with BRAF V600E-mutant metastatic CRC who receive a triplet targeted therapy regimen versus current standard of care.

New data from a recent study...

07/06/2019

Oncology

Efficacy of Trifluridine/ Tipiracil Improved With Bevacizumab in Chemo-Refractory mCRC

07/05/2019

Newly presented findings have demonstrated a significant and clinically relevant improvement in PFS and OS when bevacizumab is added to FTD/TPI in patients with chemo-refractory mCRC.

Newly presented findings have...

07/05/2019

Oncology

Survey Highlights Need to Encourage Patients With CRC to Share Experience, Provide Feedback

07/05/2019

Researchers behind a survey evaluating the unmet needs of patients living with metastatic CRC posit that an obvious preference for paper- versus online-based surveys may be the result of limited access to technology or computer illiteracy in...

Researchers behind a survey...

07/05/2019

Oncology